Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Crohn's disease: Is there a place for neurological screening?
Non-protein amino acids and neurodegeneration: The enemy within.
Physical rehabilitation interventions in nonambulatory people with multiple sclerosis: a systematic review.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
The amyloid state of proteins in human diseases.
Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Increased thalamic intrinsic oscillation amplitude in relapsing-remitting multiple sclerosis associated with the slowed cognitive processing.
The effects of salsa dance on gait and balance in multiple sclerosis (p3.053).
Therapeutic advances in tremor.
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Inhibits Microglial Proliferation and Activation via an Estrogen Receptor-Independent Mechanism.
Resting-State fMRI in MS: General Concepts and Brief Overview of Its Application.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Cerebrospinal fluid derived immunoglobulin G of different multiple sclerosis patients share mutated sequences in complementarity determining regions.
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
A 62-year-old man with fluctuating neurological deficits and skin lesions.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
Comparing adherence rates to disease modifying therapies for multiple sclerosis in commercial enrollees and Part D beneficiaries.
[Fampridine and multiple sclerosis.]
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
Pages
« first
‹ previous
…
518
519
520
521
522
523
524
525
526
…
next ›
last »